Meredith S. Irwin

Also affiliated with Hospital for Sick Children

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.705Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Papers

Driven by 16 papers — median percentile 49. Top paper: “Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults”.

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Randomized phase II trial of MIBG versus MIBG/vincristine/irinotecan versus MIBG/vorinostat for relapsed/refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy Consortium.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10500

N/A

0DataRank · unranked

4 citations

Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Anasheh Shamirian, Scarlett Czarnecki +15 more

Segmental chromosome aberrations and clinical response impact outcome of inss stage III patients ≥18 months with unfavorable histology and without MYCN amplification: A Children’s Oncology Group (COG) report.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10502

N/A

0DataRank · unranked

0 citations

Arlene Naranjo, Emily Hibbitts, Xiangming Ding, Rachelle Tibbetts, Rebekah Kennedy +7 more

LOSS OF JAK2 REGULATION VIA VHL-SOCS1 E3 UBIQUITIN HETEROCOMPLEX UNDERLIES CHUVASH POLYCYTHEMIA

UNC Libraries(2020)10.17615/74m8-nn04

N/A

0DataRank · unranked

0 citations

Michael Ohh, Roxana I. Sufan, M. Celeste Simon, Lukasz M Boba, Samuel A. Heathcote +14 more

The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors

Nature Communications(2021)10.1038/s41467-021-26526-y

N/A

0DataRank · unranked

46 citations

Yoshihito Kano, Jonathan St‐Germain, Nikolina Radulovich, Molly L. Udaskin, Ahmet Mentes +17 more

Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration

Cell Reports(2021)10.1016/j.celrep.2021.109363

N/A

0DataRank · unranked

17 citations

Alexander Gont, Lynn Kee, Ruben Dries, Kathrin Pfeifer, Bandana Sharma +11 more

Survival of patients with neuroblastoma before versus after reduction of therapy due to the change in age cut-off from 12 to 18 months in Children’s Oncology Group (COG) risk stratification.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10013

N/A

0DataRank · unranked

1 citations

Hannah Bender, Meredith S. Irwin, Michael D. Hogarty, Robert P. Castleberry, John M. Maris +4 more

Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma

Cell Reports(2023)10.1016/j.celrep.2023.112879

N/A

0DataRank · unranked

9 citations

Erez Greenstein, Martin L. Buchkovich, Ayelet Peres, Eric Santoni‐Rugiu, Lei Yang +16 more

Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

Journal of Pediatric Surgery(2024)10.1016/j.jpedsurg.2024.161896

N/A

0DataRank · unranked

6 citations

E. Stanton Adkins, Peter Mattei, Fredric A. Hoffer, Sandra L. Wootton‐Gorges, Wendy B. London +14 more

Improvements in Children’s Oncology Group neuroblastoma risk stratification through a change in age cut-off and use of INRGSS

Translational Pediatrics(2024)10.21037/tp-24-319

N/A

0DataRank · unranked

2 citations

Hannah Bousquet, Meredith S. Irwin, Michael D. Hogarty, Susan L. Cohn, Wendy B. London

Impact of an objective scoring system on initiation of therapy in patients with International Neuroblastoma Risk Group Staging System (INRGSS) stage MS neuroblastoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.10003

N/A

0DataRank · unranked

1 citations

Navin Pinto, Arlene Naranjo, Jed G. Nuchtern, Edward F. Attiyeh, Rochelle Bagatell +12 more

Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation

UNC Libraries(2024)10.17615/66tf-t772

N/A

0DataRank · unranked

0 citations

Mitsuhiko Ikura, Ivette Valencia-Sama, Benjamin Grant, Ming-Sound Tsao, Jonathan St‐Germain +14 more

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

Cancer Research(2020)10.1158/0008-5472.can-19-3068

N/A

0DataRank · unranked

114 citations

Gonzalo López, Ahsan Farooqi, Karina L. Conkrite, Thinh H. Nguyen, Shawn J. Macha +15 more

Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastoma

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102375

N/A

0DataRank · unranked

3 citations

Jae Eun Choi, Calvin Hesse, Noshad Hosseini, Alec Chu, Jin Zhou +12 more

Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group

European Journal of Cancer(2020)10.1016/j.ejca.2020.04.007

N/A

0DataRank · unranked

31 citations

Arlene Naranjo, Emily Hibbitts, Julie M. Gastier‐Foster, Rochelle Bagatell, Meredith S. Irwin +5 more

Meredith S. Irwin

Indexed papers

Top data-sharing exemplar

Papers